HCA Announces Proposed Public Offering of Senior Notes
HCA Healthcare's subsidiary, HCA Inc., has announced a proposed public offering of senior notes. The terms, including maturity, interest rate, and principal amount, will be determined based on market conditions at pricing. The net proceeds are intended for general corporate purposes, potentially including repayment of borrowings under the company's senior secured asset-based revolving credit facility. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities are acting as joint book-running managers for the offering. The offering is being made through an effective shelf registration statement filed with the SEC, with details available in the preliminary prospectus supplement and accompanying prospectus.
La sussidiaria di HCA Healthcare, HCA Inc., ha annunciato una proposta di offerta pubblica di obbligazioni senior. I termini, inclusi scadenza, tasso d'interesse e importo principale, saranno determinati in base alle condizioni di mercato al momento del prezzo. Il ricavato netto è destinato a scopi aziendali generali, potenzialmente inclusa la restituzione dei prestiti nell’ambito della linea di credito revolving garantita di senior secured dell'azienda. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities e Wells Fargo Securities stanno agendo come co-manager per l'offerta. L'offerta viene effettuata attraverso una dichiarazione di registrazione a scaffale efficace depositata presso la SEC, con i dettagli disponibili nel supplemento del prospetto preliminare e nel prospetto accompagnatorio.
La subsidiaria de HCA Healthcare, HCA Inc., ha anunciado una oferta pública propuesta de notas senior. Los términos, incluyendo el plazo, la tasa de interés y el monto principal, se determinarán en función de las condiciones del mercado al momento de la fijación de precios. Los ingresos netos están destinados a fines corporativos generales, que podrían incluir el reembolso de préstamos bajo la línea de crédito revolving garantizada por activos de la compañía. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities y Wells Fargo Securities actúan como co-gestores conjuntos para la oferta. La oferta se realiza a través de una declaración de registro en estantería efectiva presentada ante la SEC, con detalles disponibles en el suplemento del prospecto preliminar y en el prospecto acompañante.
HCA 헬스케어의 자회사인 HCA Inc.가 주니어 노트의 공모 제안을 발표했습니다. 만기, 이자율 및 원금 등 조건은 가격 결정 시 시장 상황에 따라 정해질 것입니다. 순수익은 일반 기업 목적으로 사용될 예정입니다, 이는 회사의 선순위 담보 자산 기반 회전 신용 시설의 차입금 상환을 포함할 수 있습니다. 시티그룹 글로벌 마켓, BofA 증권, JP모건 증권 및 웰스파고 증권은 이번 제안의 공동 주관사로 활동하고 있습니다. 이번 제안은 SEC에 제출된 유효한 선반 등록 명세서를 통해 이루어지며, 세부사항은 초기 증권제안 보충서와 동반된 증권제안서에서 확인할 수 있습니다.
La filiale de HCA Healthcare, HCA Inc., a annoncé une offre publique proposée de titres seniors. Les conditions, y compris l'échéance, le taux d'intérêt et le montant principal, seront déterminées en fonction des conditions du marché au moment de la tarification. Le produit net est destiné à des fins d'entreprise générales, pouvant inclure le remboursement d'emprunts dans le cadre de la ligne de crédit renouvelable garantie par des actifs de l'entreprise. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities et Wells Fargo Securities agissent en tant que co-gestionnaires pour l'offre. L'offre est réalisée par le biais d'une déclaration d'enregistrement efficace déposée auprès de la SEC, avec des détails disponibles dans le supplément de prospectus préliminaire et le prospectus accompagnateur.
Die Tochtergesellschaft von HCA Healthcare, HCA Inc., hat ein geplantes öffentliches Angebot von Senior Notes angekündigt. Die Bedingungen, einschließlich Fälligkeit, Zinssatz und Nennbetrag, werden basierend auf den Marktbedingungen zum Zeitpunkt der Preisfestsetzung festgelegt. Die Nettoerträge sind für allgemeine Unternehmenszwecke vorgesehen, möglicherweise einschließlich der Rückzahlung von Darlehen im Rahmen der gesicherten revolvierenden Kreditlinie des Unternehmens. Citigroup Global Markets, BofA Securities, J.P. Morgan Securities und Wells Fargo Securities fungieren als gemeinsame stille Leiter für das Angebot. Das Angebot erfolgt über eine wirksame Shelf-Registrierungsanmeldung, die bei der SEC eingereicht wurde, mit Einzelheiten, die im vorläufigen Prospektnachtrag und im Begleitprospekt verfügbar sind.
- Potential to strengthen HCA's financial position through debt refinancing
- Access to capital markets for funding general corporate purposes
- Utilization of an effective shelf registration statement for efficient offering process
- Potential increase in long-term debt obligations
- Possible dilution of existing shareholders' equity
- Market conditions may affect the final terms of the offering
HCA Healthcare's proposed senior notes offering is a strategic financial move that could have significant implications for the company's capital structure and liquidity position. The offering's primary purpose of general corporate purposes, including potentially repaying borrowings under their revolving credit facility, suggests a focus on debt management and financial flexibility.
This move could be viewed positively as it may help HCA optimize its debt profile and potentially reduce interest expenses if market conditions are favorable. However, investors should closely monitor the final terms of the notes, particularly the interest rate and maturity, to assess the long-term impact on HCA's financial health.
The involvement of major financial institutions as joint book-running managers adds credibility to the offering. Overall, this could be a prudent financial strategy for HCA, potentially strengthening its balance sheet and enhancing its ability to navigate future challenges or opportunities in the healthcare sector.
HCA's decision to issue senior notes comes at a time when the healthcare sector is facing evolving challenges, including potential policy changes and ongoing pandemic-related pressures. This move suggests HCA is proactively managing its financial position to maintain operational flexibility.
The market's reception to this offering will be important to watch. If HCA secures favorable terms, it could indicate strong investor confidence in the company's future prospects and the broader healthcare sector. Conversely, less favorable terms might suggest market concerns about industry headwinds.
Investors should consider how this offering compares to recent debt issuances by HCA's peers. A successful placement could potentially strengthen HCA's competitive position by providing additional resources for strategic initiatives or weathering market uncertainties. This move underscores the importance of financial agility in the current healthcare landscape.
Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are acting as the joint book-running managers for the offering.
The offering of the senior notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue,
You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the senior notes or any other security and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
FORWARD-LOOKING STATEMENTS
Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and HCA assumes no obligation to update the information included in this press release. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about HCA’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond HCA’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although HCA believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Company’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 16, 2024 and our other filings with the Securities and Exchange Commission. Unless otherwise required by law, HCA also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.
All references to the “Company” and “HCA” as used throughout this press release refer to HCA Healthcare, Inc. and its affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240804864116/en/
INVESTOR CONTACT:
Frank Morgan
615-344-2688
MEDIA CONTACT:
Harlow Sumerford
615-344-1851
Source: HCA Healthcare
FAQ
What is the purpose of HCA Healthcare's proposed senior notes offering?
Who are the joint book-running managers for HCA's senior notes offering?
How can investors obtain information about HCA's senior notes offering?
What factors will determine the terms of HCA's senior notes offering?
